[go: up one dir, main page]

EP3630090A4 - Combination therapy for cancer using botanical compositions and enzalutamide - Google Patents

Combination therapy for cancer using botanical compositions and enzalutamide Download PDF

Info

Publication number
EP3630090A4
EP3630090A4 EP18805621.2A EP18805621A EP3630090A4 EP 3630090 A4 EP3630090 A4 EP 3630090A4 EP 18805621 A EP18805621 A EP 18805621A EP 3630090 A4 EP3630090 A4 EP 3630090A4
Authority
EP
European Patent Office
Prior art keywords
enzalutamide
cancer
combination therapy
botanical compositions
botanical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18805621.2A
Other languages
German (de)
French (fr)
Other versions
EP3630090A1 (en
Inventor
James Dao
Jeffrey Dao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genyous Biomed International
Original Assignee
Genyous Biomed International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genyous Biomed International filed Critical Genyous Biomed International
Publication of EP3630090A1 publication Critical patent/EP3630090A1/en
Publication of EP3630090A4 publication Critical patent/EP3630090A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP18805621.2A 2017-05-26 2018-05-30 Combination therapy for cancer using botanical compositions and enzalutamide Withdrawn EP3630090A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762511358P 2017-05-26 2017-05-26
PCT/US2018/000120 WO2018217237A1 (en) 2017-05-26 2018-05-30 Combination therapy for cancer using botanical compositions and enzalutamide

Publications (2)

Publication Number Publication Date
EP3630090A1 EP3630090A1 (en) 2020-04-08
EP3630090A4 true EP3630090A4 (en) 2021-04-07

Family

ID=64395849

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18805621.2A Withdrawn EP3630090A4 (en) 2017-05-26 2018-05-30 Combination therapy for cancer using botanical compositions and enzalutamide

Country Status (2)

Country Link
EP (1) EP3630090A4 (en)
WO (1) WO2018217237A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110643582B (en) * 2019-09-29 2021-07-27 浙江工业大学 A kind of method for extracting SOD from fresh sea buckthorn fruit
WO2022040365A1 (en) * 2020-08-18 2022-02-24 Curators Of The University Of Missouri Compositions and methods of treatment comprising tumor-targeting bacteria and chemotherapy or immunotherapy agent
WO2025003967A1 (en) * 2023-06-30 2025-01-02 Future Biome Corporation Polysaccharide mixture obtainable by fermentation of ganoderma sessile followed by ultrafiltration and uses of this mixture
CN117064899B (en) * 2023-10-13 2024-01-23 暨南大学附属第一医院（广州华侨医院） Application of ganoderic acid A in the preparation of drugs for the treatment of castration-resistant prostate cancer
CN117778322B (en) * 2023-12-17 2025-02-07 苏州拓维生物技术有限公司 A method for screening cell lines resistant to enzalutamide and its application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012061790A1 (en) * 2010-11-04 2012-05-10 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and bicalutamide
WO2014197519A1 (en) * 2013-06-03 2014-12-11 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and docetaxel
US20150366882A1 (en) * 2011-02-03 2015-12-24 Pop Test Oncology Limited Liability Company System and Method for Diagnosis and Treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050196409A1 (en) * 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes
CA2920317A1 (en) * 2013-08-12 2015-02-19 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
WO2016179002A1 (en) * 2015-05-01 2016-11-10 The Regents Of The University Of California Compositions and methods for treatment of cancer
CN105194550B (en) * 2015-10-15 2019-03-01 华东师范大学 A kind of Traditional Chinese medicine compound composition and its application in anti-prostate cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012061790A1 (en) * 2010-11-04 2012-05-10 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and bicalutamide
US20150366882A1 (en) * 2011-02-03 2015-12-24 Pop Test Oncology Limited Liability Company System and Method for Diagnosis and Treatment
WO2014197519A1 (en) * 2013-06-03 2014-12-11 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and docetaxel

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KIMURA TAKAHIRO ET AL: "Re: Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial", EUROPEAN UROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 71, no. 2, 3 September 2016 (2016-09-03), pages 303, XP029865174, ISSN: 0302-2838, DOI: 10.1016/J.EURURO.2016.08.056 *
See also references of WO2018217237A1 *

Also Published As

Publication number Publication date
EP3630090A1 (en) 2020-04-08
WO2018217237A1 (en) 2018-11-29

Similar Documents

Publication Publication Date Title
IL271946A (en) Combination cancer therapy
EP3585433A4 (en) Therapeutic compositions and related methods for photoimmunotherapy
IL276808A (en) Compositions and methods for cancer treatment
EP3268387A4 (en) Compositions and methods for enhancing the efficacy of cancer therapy
EP3630090A4 (en) Combination therapy for cancer using botanical compositions and enzalutamide
SG11202106295WA (en) Compositions and methods for cancer therapy
EP3688023A4 (en) Methods and compositions for cancer treatment
EP3638293A4 (en) Methods and compositions for treating cancer
EP3469101A4 (en) Methods and compositions for prostate cancer diagnosis and treatment
EP3737383A4 (en) Synergistic cancer treatment
EP3638270A4 (en) Compositions and methods for enhancing hyperthermia therapy
EP3714043A4 (en) Compositions and methods for treating cancer
EP3256473A4 (en) Synergistic cancer treatment
EP3576746A4 (en) Cancer therapeutic
EP3169333A4 (en) Methods and compositions for enhancing cancer therapy
EP3003490A4 (en) Combination therapy for prostate cancer using botanical compositions and docetaxel
EP3672582A4 (en) Compositions and methods for treating cancer
EP3290051A4 (en) Pharmaceutical composition for treating and/or preventing cancer
SG11202000724XA (en) Methods and compositions for the treatment of cancer
EP3365015A4 (en) Compositions and methods for immune-mediated cancer therapy
IL274866A (en) Compositions and methods for cancer therapy
EP3285763A4 (en) Compositions for the treatment of cancer
HK40093210A (en) Methods and compositions for the treatment of cancer
HK40106688A (en) Combination therapy against cancer
HK40103983A (en) Cancer treatment

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191230

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210304

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/46 20060101ALI20210226BHEP

Ipc: A61K 9/08 20060101ALI20210226BHEP

Ipc: A61K 31/4166 20060101ALI20210226BHEP

Ipc: A61K 36/539 20060101ALI20210226BHEP

Ipc: A61K 9/00 20060101ALI20210226BHEP

Ipc: A61P 35/00 20060101ALI20210226BHEP

Ipc: A61K 31/337 20060101AFI20210226BHEP

Ipc: A61K 36/074 20060101ALI20210226BHEP

Ipc: A61K 36/537 20060101ALI20210226BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20221201